MLYS
Mineralys Therapeutics Inc.
$43.36
+$1.20(+2.83%)
67
Overall
60
Value
100
Tech
42
Quality
Market Cap
$2.50B
Volume
1.30M
52W Range
$8.24 - $42.71
Target Price
$43.75
Key Metrics Overview
| Market Cap | $2.50B | P/E Ratio | N/A |
| 52W High | $42.71 | 52W Low | $8.24 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | N/A | 52W Position | 101.9% |
| Overall Score | 67 | Value Score | 60 |
| Quality Score | 42 | Technical Score | 100 |
Growth Analysis
| EPS Current Est | $-2.95 | EPS Next Est | $-3.06 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MLYS | $43.36 | +2.8% | 1.30M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Mineralys Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW